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Research
The tobacco industry has a history of
manipulating science regarding both active
and passive smoking to serve its political,
legal, and regulatory needs (Barnes and Bero
1998; Barnoya and Glantz 2002, 2005; Bero
2005b; Bero et al. 1994; Glantz et al. 1996;
Hirschhorn and Bialous 2001; Hong and
Bero 2002; Muggli et al. 2001; Ong and
Glantz 2001). Public concern about the
health effects of secondhand smoke (SHS)
increased sharply in 1981 when Hirayama
(1981) linked SHS to lung cancer in non-
smokers, followed by the 1986 Surgeon
General’s Report, The Health Consequences of
Involuntary Smoking [U.S. Department of
Health and Human Services (DHHS) 1986]
and National Research Council (NRC)
reports on SHS (NRC 1986b) and airliner
cabin air quality (NRC 1986a). Just as it did
when confronted with evidence in the 1960s
that smoking caused lung cancer in smokers
(Bero et al. 1995; Glantz et al. 1996), the
tobacco industry responded with research
designed to “establish a controversy” about
the evidence linking SHS with disease (Barnes
and Bero 1996, 1997, 1998; Barnes et al.
1995; Barnoya and Glantz 2002, 2005; Bero
2003, 2005b; Bero et al. 1994, 2001, 2005;
Hirschhorn and Bialous 2001; Hong and
Bero 2002; Muggli et al. 2001; Ong and
Glantz 2001; Schotland and Bero 2002). This
effort included industry personnel designing
and supervising studies that undermined the
connection between SHS and lung cancer
(Lee 1995) and contested the conclusion that
there were substantial levels of toxicants in air-
liners where smoking was allowed (Malmfors
et al. 1989). Both these reports were published
under the names of nonindustry authors and
minimized unfavorable (to the tobacco indus-
try) results (Hong and Bero 2002; Neilsen
and Glantz 2003; Yano 2005). 
In 1988, in response to a citizen petition
seeking a standard prohibiting smoking in
indoor workplaces (Public Citizen 1987), the
U.S. Occupational Safety and Health
Administration (OSHA) obtained a written
analysis of the literature on SHS (Meridian
Research 1988) that reported that the litera-
ture, though compelling, relied on data from
residential exposures only and concluded,
“What seems unequivocally clear at this time,
is the need to resolve these issues by means of
personal sampling to ascertain the relative
contribution of workplace exposure to a non-
smoker’s overall exposure to environmental
tobacco smoke from all sources.” OSHA did
not act on this recommendation or make the
report public.
In June 1991, the National Institute for
Occupational Safety and Health (NIOSH)
issued the Current Intelligence Bulletin
Environmental Tobacco Smoke in the Workplace:
Lung Cancer and Other Health Effects (NIOSH
1991), which urged employers to protect
employees from SHS by prohibiting smoking
in all workplaces. This publication was fol-
lowed in 1992 by the U.S. Environmental
Protection Agency (EPA) risk assessment that
identified SHS as a Group A (human) car-
cinogen (U.S. EPA 1992). These reports,
combined with continued pressure from
health advocates (Bryan-Jones and Bero 2003;
Public Citizen 1987), led OSHA in 1994 to
propose a workplace standard on indoor air
quality that included substantial restrictions
on indoor smoking (OSHA 1994). OSHA
assumed that SHS exposure levels at work
would be at least as high as those in homes.
The actual levels of SHS exposure were a
potentially important issue in the OSHA rule-
making because, at the time, risk estimates for
lung cancer were based on studies of non-
smoking spouses married to smokers. 
The tobacco industry responded with the
“16 Cities Study” (Jenkins et al. 1996), which
was specifically conceived and designed to
oppose the OSHA regulation. It was the ﬁrst
large study using personal monitoring equip-
ment to sample airborne SHS constituents in
both workplaces and worker homes and to
compare those exposures to each other. The
study was designed by R.J. Reynolds Tobacco
Company (RJR) scientists, and all of the ﬁeld
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[Online 29 August 2006]work and laboratory analyses for the study
were done by RJR personnel. RJR exercised
substantial control of the research throughout
its conduct and analysis. The 16 Cities Study
presentations to OSHA (Jenkins 1994a,
1994b, 1994c, 1995a; Jenkins and Guerin
1994) and published 1996 paper (Jenkins et al.
1996) did not disclose the full involvement of
RJR and other tobacco industry scientists. The
study concluded that home SHS exposures
were two to four times greater than workplace
exposures. The purpose of the 16 Cities Study
was to affect policy making, not to advance sci-
entific knowledge; the results as presented
(Jenkins et al. 1996) served the tobacco indus-
try’s goal of preventing regulation of smoking.
A careful review of the 16 Cities data, however,
reveals that smoking was restricted in most of
the “smoking workplaces” and that few ciga-
rettes were observed being smoked there.
Presenting the data in a way that accounts for
actual smoking in workplaces reveals, in con-
trast to the interpretation presented by the
tobacco industry and the researchers it funded,
that requiring smoke-free workplaces would
cut the total SHS exposure of those living with
smokers in half and all but eliminate SHS
exposure for those living in nonsmoking
homes, providing a significant worker safety
and public health beneﬁt.
Methods
Between September 2004 and October 2005
we searched tobacco industry documents and
Deposition and Trial Testimony Archive
(DATTA) transcripts in the University of
California, San Francisco Legacy Tobacco
Documents Library (http://legacy.library.
ucsf.edu and http://ltdlftd.library.ucsf.edu/),
the British American Tobacco Document
Archive (http://bat.library.ucsf.edu), and
Tobacco Documents Online (http://tobac-
codocuments.org). Initial search terms were
Roger Jenkins, 16 Cities, and reference (Bates)
numbers near relevant documents. After iden-
tifying the ﬁrst documents, we used a snowball
strategy to locate new documents. A total of
about 500 relevant documents were reviewed.
We used the Access World News Internet
newspaper archives (http://infoweb.newsbank.
com) and other Internet resources to find
information on administrative hearings and
actions and on tobacco industry lawsuits in
which Roger Jenkins was involved as a witness
or potential witness, and the transcripts of the
1995 OSHA hearings on the proposed Indoor
Air Quality Standard (OSHA 1995).
We used tabulated data from the 16 Cities
Study (Jenkins and Counts 1999; Jenkins
et al. 1996) to illustrate that a different analy-
sis (stratiﬁcation by smoking policy) and pre-
sentation of the results would lead to different
conclusions from those the tobacco industry
and its consultants reported. 
Results
Table 1 lists key events related to the origin,
conduct, and use of the 16 Cities Study.
The origin of the 16 Cities Study. At its
11 April 1991 meeting, the Tobacco Institute
(TI) Executive Committee (TI 1991c)
approved an “EPA/OSHA Strategic Plan” (TI
1991b) for opposing U.S. EPA and OSHA
action on secondhand tobacco smoke. (TI was
the tobacco industry’s political and lobbying
organization.) The plan sought to prevent
release of the U.S. EPA risk assessment of SHS
(U.S. EPA 1992) and to forestall SHS legisla-
tion at federal, state, and local levels. At the
August 1991 TI Executive Committee meet-
ing, separate U.S. EPA and OSHA project sci-
entiﬁc research recommendations (TI 1991a)
were presented (TI 1991d) by Susan Stuntz, TI
Vice President for Public Relations, and John
Rupp, a Covington & Burling attorney who
served as counsel to the Institute and played a
key role in a wide range of SHS issues (Barnoya
and Glantz 2002; Drope and Chapman 2001;
Muggli et al. 2001, 2003, 2004). The stated
objective of the “OSHA Projects” scientific
research was to “encourage adoption of a venti-
lation standard and to discourage adoption of a
smoking ban or of a standard that requires sep-
arate ventilation for areas where smoking is
allowed” (TI 1991a). This objective ﬁts into the
industry’s overall strategy of presenting ventila-
tion as an alternative to smoke-free environ-
ments (Bialous and Glantz 2002; Bryan-Jones
and Bero 2003; Drope et al. 2004). Among the
four research projects the report recommended
to support this objective was one to “develop
data demonstrating ... that ETS [environmental
tobacco smoke, the term the tobacco industry
developed for SHS] exposures in the typical
workplace are too low to support the notion of
a signiﬁcant risk” and “to compile for the ﬁrst
time all available data on levels of ETS and
other pollutants in the home, in the workplace
and in social settings” (TI 1991a).
The only large SHS exposure study
(Turner et al. 1992) available at that time
(funded secretly by the tobacco industry) was
conducted by Healthy Buildings International
(HBI) and used area sampling in 585 ofﬁces
(Barnes et al. 1995; Turner et al. 1992). HBI
was a frequent contributor to the industry’s
public relations campaign on “sick building
syndrome” and ventilation as an alternative to
smoke-free environments (Barnes et al. 1995;
Drope et al. 2004). The proposed new study
would generate personal sampling data for
workplace and away-from-work SHS expo-
sures of a large number of subjects for 24 hr in
geographically diverse nonindustrial environ-
ments, providing the data the NIOSH
Bulletin (NIOSH 1991) suggested in 1991.
The origin of R.J. Reynolds’ role in the
16 Cities Study. Seven years earlier, in 1984,
RJR Research and Development implemented
a “Study Plan” (Colucci 1984) to provide RJR
with data on exposure to SHS in response to
growing public concern about SHS. The plan
had two goals: a) to develop methods to quan-
titatively assess SHS exposures in homes,
workplaces, and public places using chemical
markers for SHS; and b) to develop “chemical
indices of ETS components that could be
measured in body fluids” (Colucci 1984).
RJR’s new ETS research unit was led by
Charles Green (Colucci 1985). Green was also
a member of the TI’s ETS Advisory Group
that reviewed and recommended funding of
external research projects by the TI. Later, he
served on the board of directors of the Center
for Indoor Air Research (CIAR), the industry
agency created to replace the ETS Advisory
Group to fund external research on SHS
(Barnes and Bero 1996). 
In mid-1992, RJR Research and
Development chemist Michael Ogden pro-
posed to CIAR that it sponsor a nationwide
SHS exposure assessment survey specifically
for industry use in opposing any smoke-free
workplace requirement in the anticipated
OSHA indoor air quality standard (CIAR
1994; Green 1992, 1995a, 1997a, 1997b;
Ogden 1997; OSHA 1995, 11614–11618).
CIAR described the proposed study to its
board of directors as “a very significant
enhancement over RJR nine city study which
was recently presented to EPA SAB [Science
Advisory Board] panel on ETS” (CIAR 1992;
Davis and Stiles 1992), which was considering
the then-proposed U.S. EPA risk assessment
on SHS. The RJR nine city study compared
reported smoking status by questionnaire with
smoking status assessed by cotinine (Ogden
et al. 1997); it did not have measurements of
SHS exposure. The CIAR executive commit-
tee wanted to do the project, but its members
identiﬁed two problems.
The committee believed there was no exist-
ing equipment to do the personal monitoring
and no laboratory to conduct the chemical
analyses (Green 1997b). Although RJR scien-
tists had the technical expertise to do the labora-
tory analyses (OSHA 1995, 11659–11661;
Wheeler 1988), the RJR laboratory capacity to
handle such a large volume of work was not
known. CIAR contacted scientists at Oak Ridge
National Laboratory (ORNL) who had previ-
ously worked with CIAR on SHS research for a
cost estimate to overcome these obstacles (Green
1997b; OSHA 1995, 11618–11619). Ogden
offered that he and his colleagues at RJR would
design and construct the personal sampling
equipment, collect the samples, and make the
analytical measurements for the proposed study
(Green 1997b) with others collecting the data. 
The design of the 16 Cities Study. On
28 January 1993, RJR’s Ogden scheduled a
meeting of RJR, Bellomy Research, Inc.,
ORNL, and CIAR to continue discussion of
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research company, was a frequent contractor
for human subject recruitment for RJR in-
house scientiﬁc studies. The agenda shows that
RJR was in charge of the “scope and objec-
tives” of the study and that the four organiza-
tions would discuss and reach agreement on
major components of the study, including the
number of cities, number of participants, deﬁ-
nition of cells, and restrictions on subject par-
ticipation (Ogden 1993).
Roger Jenkins, an analytical chemist at
ORNL, submitted the ORNL proposal
requested by CIAR for the project on 16
February 1993 (Broin 1997, 14531–14532;
Jenkins and Guerin 1993), and the CIAR
board of directors approved $1.2 million in
“directed study” funding for a 12 cities study
project on 19 February 1993 (CIAR 1993,
1994; Heck 1993). A “directed,” “applied,” or
“special-reviewed” project funded by CIAR
was not peer reviewed by the CIAR scientiﬁc
advisory board; these projects were used to
meet the industry’s political and legal needs
(Barnes and Bero 1996; Drope and Chapman
2001). CIAR issued separate contracts with
RJR, Bellomy, and ORNL (Eisenberg 1993;
Heck 1993; OSHA 1995, 9777–9778): for
RJR, $360,000 for sampling equipment and
materials, ﬁeld sampling, laboratory analysis of
samples, and compilation of raw data; for
Bellomy, $480,000 for subject recruitment and
selection; and for ORNL, $350,000 for quality
assurance and control, and data interpretation
and reporting. The overall manager of the
project appears to have been CIAR executive
director Max Eisenberg, whom Jenkins
described to OSHA as his boss and the project
ofﬁcer (OSHA 1995, 9876–9877).
The study funded by CIAR involved
recruiting 100 nonsmoking subjects in each of
12 cities distributed geographically across the
United States (Ogden 1995). Subjects were to
be recruited to populate equally each of
4 cells in a 2 × 2 design (Bailey 1993; Jenkins
and Guerin 1993): smoking home/smoking
workplace (SH/SW, Cell 1), smoking home/
nonsmoking workplace (SH/NW, Cell 2),
nonsmoking home/smoking workplace
(NH/SW, Cell 3), and nonsmoking home/
nonsmoking workplace (NH/NW, Cell 4). 
To determine exposure to SHS, each
subject wore a personal sampling pump during
work and a separate personal sampling pump
Barnes et al.
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Table 1. 16 Cities Study timeline.
Date Government or public health action Tobacco industry action
1981 Hirayama study on lung cancer in nonsmoking wives of Japanese smokers 
published (Hirayama 1981)
1984 RJR R&D implements SHS Study Plan (Colucci 1984)
1986 Surgeon General issues report on involuntary smoking (U.S. DHHS 1986)
NRC issues report on measuring exposures and 
assessing health effects of SHS (NRC 1986b)
NRC issues study on air quality and safety in airliner cabins (NRC 1986a)
1987 Congress passes law ending smoking on short airline ﬂights 
Citizen petition ﬁled seeking emergency OSHA standard on workplace smoking 
(Public Citizen 1987)
1988 Philip Morris promotes tobacco industry study of in-ﬂight air quality
Consultant recommends to OSHA it conduct personal sampling study of 
workplace SHS exposure (Meridian Research 1988)
1989 OSHA denies citizen petition
Tobacco industry’s in-ﬂight air quality study published (Malmfors et al. 1989)
1991 Tobacco Institute Executive Committee approves U.S. EPA/OSHA Strategic Plan
NIOSH issues Current Intelligence Bulletin on SHS (NIOSH 1991)
Tobacco Institute Executive Committee adopts U.S. EPA and OSHA scientiﬁc 
research plan
Tobacco industry funds Japanese spousal study to challenge Hirayama ﬁndings
OSHA publishes Notice of Request for Information on Occupational Exposure 
to Indoor Air Pollutants (OSHA 1991)
1992 RJR proposes nationwide personal sampling SHS exposure assessment to Center for
Indoor Air Research (CIAR)
CIAR recruits Jenkins and Guerin of Oak Ridge National Laboratory to front for 
nationwide SHS study
EPA publishes its risk assessment Respiratory Health Effects of Passive
Smoking: Lung Cancer and Other Disorders (U.S. EPA 1992)
1993 CIAR funds 12 Cities Study for nationwide SHS exposure assessment
RJR scientists conduct ﬁeldwork and laboratory analysis for 12 Cities Study
Jenkins complains to CIAR about shortcomings in data and recommends adding 4 
more cities to study
1994 CIAR funds additional 4 cities for study
Jenkins and Guerin present preliminary ﬁndings for cities 1–6 to OSHA staff
OSHA issues its Notice of Proposed Rulemaking on Indoor Air Quality
RJR scientists conduct ﬁeld work and laboratory analysis for 4 additional cities
Jenkins submits Comments on Proposed Rulemaking to OSHA with data from ﬁrst 
12 cities (Jenkins 1994b)
CIAR submits ORNL Interim Report No. 3 covering cities 1–12 to OSHA (Jenkins and
Guerin 1994)
Jenkins submits Addendum to Comments on Proposed Rulemaking updating data to 
include all 16 cities (Jenkins 1994a)
1995 Jenkins testiﬁes at OSHA Hearing on Indoor Air Quality Standard
Japanese spousal study journal article published (Lee 1995)
1996 16 Cities Study journal article published (Jenkins et al. 1996)
1997 16 Cities Study rejected as unreliable by Judge Kaye in ﬂight attendants’ SHS 
litigation (Broin 1997)
1999 Journal article published on 16 Cities smoke density data (number of cigarettes 
being smoked) omitted from original 16 Cities Study (LaKind et al. 1999)
2001 OSHA withdraws Notice of Proposed Rulemaking on Indoor Air Quality
Abbreviations: CIAR, Center for Indoor Air Research; ETS, environmental tobacco smoke; ORNL, Oak Ridge National Laboratory; R&D, research and development; TI, Tobacco Institute.away from work for the balance of a 24-hr
period. In addition, subjects kept a written
diary of the number of cigarettes being smoked
within 100 ft of them every hour during the air
sampling. The samples were analyzed to deter-
mine SHS exposure based on three vapor
phase (nicotine, 3-ethenylpyridine, myosmine)
and five particulate phase SHS constituents
(respiratory suspended particulates, ultraviolet
absorbing particulate matter, ﬂuorescing par-
ticulate matter, solanesol, scopoletin). 
Salivary cotinine (a stable metabolite of
nicotine) samples were obtained from each
subject to conﬁrm that they were nonsmokers
and as a measure of the amount of nicotine
inhaled (NRC 1986b; U.S. DHHS 1986;
U.S. EPA 1992).
The conduct of the 16 Cities Study.
Bellomy designed and executed the plan for
recruiting and selecting the human subject par-
ticipants and selected the 12 cities with concur-
rence by RJR (Bailey 1993; Broin 1997,
14537–14540; OSHA 1995, 11666–11670).
The selection criteria for cities included disper-
sion among the nine U.S. Census Bureau
Regions and a variety of weather conditions
(OSHA 1995, 11666–11670).
Field sampling for the original 12 cities
study began on 13 May 1993 (Maiolo 1993),
and was managed by Katherine Maiolo, an RJR
chemist. Maiolo reported her ﬁeld work directly
to RJR’s Green. RJR conducted all of the labo-
ratory analysis of the air and salivary cotinine
samples (Broin 1997, 14531–14533; Green
1995a), with the air sample analyses under the
direction of RJR’s Ogden, and the salivary coti-
nine samples were processed in a RJR biological
chemistry research unit (OSHA 1995, 11604). 
In a 28 December 1993 letter to CIAR’s
Eisenberg (Jenkins 1993), Jenkins criticized
some of Bellomy’s participant recruitment
(failure to recruit equally for the four exposure
cells) and complained about RJR’s “analytical
difficulties” with salivary cotinine data from
one city. Jenkins concluded that, as a result,
the data set was limited in its usefulness, which
would “restrict the generalization of the con-
clusions to a relatively narrow focus” (Jenkins
1993). After completion of the ﬁeld sampling
and analyses of the samples from the original
12 cities, the data set was not equally popu-
lated (25% per cell), but heavy on the non-
smoking home/nonsmoking workplace data
(Cell 4) with 686 (57%) subjects, and light on
the smoking home/smoking workplace
(Cell 1) with only 136 subjects (11%). Jenkins
reported these problems to CIAR because “one
of the most important objectives of this study
is the relationship between time-averaged ETS
exposure and salivary cotinine levels for indi-
viduals who live and work around smokers,
compared with those who live in [sic] work in
truly non-smoking environments, any loss of
Cell 1 (SH/SW) participant data is signiﬁcant”
(Jenkins 1993). Jenkins suggested adding
four more cities to the study, with particular
emphasis on increasing the percentage of
smoking home/smoking workplace (Cell 1)
participants (Jenkins 1994e).
The CIAR board of directors approved an
additional $440,000 to expand the study to 16
cities to obtain the additional data Jenkins had
suggested (Heck 1994), but with the direction
that a technical meeting be held between the
CIAR board members and ORNL (Eisenberg
1994) “to ﬁnalize the experimental protocols
to bring the ETS Exposure Study” to conclu-
sion. Field sampling on the additional four
cities was completed on 18 June 1994 (Maiolo
1994), bringing the total sample size to 1,564
people (507 males, 1,057 females).
The OSHA proceedings. Jenkins and his
ORNL supervisor Mike Guerin were identiﬁed
as the co-principal investigators of the
16 Cities Study throughout the OSHA presen-
tations (Jenkins 1994c; Jenkins and Guerin
1993, 1994, 1995a). A “Project Status and
Summary” was presented to the OSHA staffers
(Jenkins 1994d) on 16 March 1994 that iden-
tiﬁed all 16 cities, but included exposure data
only for cities 1 through 6 and salivary cotinine
data only for city 1. It showed exposures in the
home 5–10 times higher than in the workplace
for 6 of the 7 airborne exposure markers sam-
pled and nearly twice for respirable suspended
particles. The number of cigarettes that sub-
jects reported being smoked in smoking work-
places was reported; these showed increased
levels of smoke constituents as the number of
cigarettes reported being smoked increased.
However, the smoking workplaces category
included workplaces in which no smoking was
observed by subjects.
Less than a month later, on 5 April 1994,
OSHA issued its Notice of Proposed Rule-
making on Indoor Air Quality (OSHA 1994)
to adopt a workplace safety and health stan-
dard that included extensive restrictions on
smoking in the workplace (Bryan-Jones and
Bero 2003; OSHA 1994). The public was
invited to submit formal comments on the
proposed rule, with an 13 August 1994 dead-
line. These comments would form the basis
for the planned public administrative hearing
on the proposed rule.
Jenkins and Guerin submitted their
Interim Report No. 3 (Jenkins and Guerin
1994) based on data from the ﬁrst 12 cities to
CIAR on 10 August 1994, just in time for
CIAR to submit it to OSHA as CIAR’s com-
ment. Interim Report No. 3 stated that it
appeared the workplace was not the dominant
source of SHS exposure, and that it is inaccu-
rate to assume that workplace and residential
exposures are comparable.
Jenkins also filed a comment (Jenkins
1994b) challenging OSHA’s measure of SHS
exposure because OSHA considered only
duration of exposure to SHS without consid-
ering SHS concentration, and noting that the
pending 16 Cities Study would provide the
first determination of personal exposure to
SHS constituents. 
When Jenkins presented the 16 Cities
Study results at the OSHA hearing, he charac-
terized it as the most representative study of
U.S. workplaces that had ever been under-
taken (Jenkins and Guerin 1995b). Later, RJR
lead SHS scientist Green defended (Green
1997a) the 16 Cities Study (Jenkins et al.
1996) in a response to a journal article criticiz-
ing CIAR funding of tobacco-related research
such as the 16 Cities Study (Barnes and Bero
1996); Green described the 16 Cities Study as
the only authoritative SHS study OSHA had
before it for consideration on the proposed
Indoor Air Quality Standard and “the largest,
most relevant, and most representative study
of its kind, using the most appropriate analyti-
cal methodology” (Green 1997a). Green iden-
tified himself in the response as an RJR
scientist and CIAR Board member, but he did
not disclose his extensive role in origin and
conduct of the study.
Omitted data on the amount of smoking
near study subjects. During Jenkins’ presenta-
tion at the 5 January 1995 OSHA hearing,
Matt Myers, representing public health organi-
zations at the hearing, asked Jenkins about the
determinants of the level of SHS described in
The Chemistry of Environmental Tobacco
Smoke: Composition and Measurement (Guerin
et al. 1992), a book on SHS that CIAR com-
missioned Jenkins and Guerin to write. Jenkins
agreed that one of the relevant determinants of
SHS exposure he and Guerin described was the
number of cigarettes being smoked in the area
being studied (OSHA 1995, 9904–9911).
None of the data submitted to OSHA from
the completed 16 Cities Study (Jenkins 1994a,
1994c, 1995a; Jenkins and Guerin 1994),
however, included the data (Bellomy Research
1993a, 1993b) on the number of cigarettes
being smoked within 100 ft of the experimen-
tal subjects each hour, which show no smoking
or relatively little smoking occurring in many
workplaces designated as smoking workplaces
in the study. Myers asked why these data were
omitted. Jenkins responded that the raw data
in the diaries were self-reported observations
and expressed skepticism about their value
(OSHA 1995, 9904–9911).
In 1997, however, a study (Sapphire
Group 1997) using the 16 Cities data set for
CIAR by the Sapphire Group, a risk assess-
ment consulting firm (Tardiff 1996, 1997,
1998), reported that the 16 Cities data showed
a significant association between workplace
concentrations of SHS components and the
number of cigarettes being smoked. 
In 1999, Jenkins coauthored a paper
(LaKind et al. 1999) with two people from the
Tobacco industry SHS study supports smoke-free work
Environmental Health Perspectives • VOLUME 114 | NUMBER 12 | December 2006 1893Sapphire Group and others using the 16 Cities
data on the number of cigarettes being
smoked, and concluded that the number of
cigarettes smoked had an impact on the SHS
exposures measured. Jenkins did not comment
on why the data on the number of cigarettes
being smoked at work—which he had viewed
skeptically at the OSHA hearing (OSHA
1995, 9904–9911) and omitted from his origi-
nal publication of the 16 Cities Study (Jenkins
et al. 1996)—were now worthy of publication.
The posthearing period. After Jenkins’
5 January 1995 presentation at the OSHA
Hearing, Green (1995b), the RJR representa-
tive on the CIAR Board and manager of RJR’s
component of the 16 Cities Study, wrote his
fellow board members on 13 April 1995, rec-
ommending that the CIAR board assemble a
team of knowledgeable scientists to review
with Jenkins his 5 January 1995 OSHA pre-
sentation. Jenkins summarized the recommen-
dations made by the CIAR scientiﬁc team to
change how the data were to be presented in
the future (Jenkins 1995b). All of the changes
recommended by the CIAR scientific team
appeared in Jenkins’ posthearing comments
(Jenkins 1995a). 
Discussion
Secondhand tobacco smoke is the major source
of indoor air pollution in the United States
and globally, surpassing most other sources for
particulate matter, volatile organic compounds,
and most toxic chemicals in the home and the
nonindustrial workplace, except in some devel-
oping countries where biomass fuels are
burned indoors for heating and cooking. The
16 Cities Study is one of the largest studies
ever conducted of occupational exposures to
SHS. Understanding the limitations of the
study, and what information can be gleaned
from the study, are of great value to all con-
cerned about indoor air pollution. 
The 16 Cities Study reported that expo-
sures in homes with unrestricted smoking were
two to four times higher than exposures in
workplaces where smoking was allowed, and
concluded that exposures in the workplace
were only 30–60% of those estimated by
OSHA from residential exposure data for
average workers, and only 15–20% for the
most highly exposed workers. OSHA had
based its risk assessment on residential SHS
exposure risk because of the acknowledged
lack of research on the concentration and dis-
tribution of SHS components in the work-
place (NIOSH 1991; OSHA 1994) by
assuming that residential and workplace expo-
sures to SHS were comparable. The 16 Cities
Study challenged this assumption because it
provided workplace SHS exposure data and
compared that exposure to at-home exposures
for the same person. In addition, the 16 Cities
Study is particularly important because its
widespread use in legislative and regulatory
hearings to substantiate the tobacco industry’s
long-standing argument that smoking is not a
major source of indoor air pollution (Bryan-
Jones and Bero 2003; Drope et al. 2004).
Assuming that the 16 Cities data are valid,
however, a more appropriately formulated
analysis results in the opposite conclusions.
Definition of a “smoking workplace.”
Although in his testimony to OSHA Jenkins
classified workplaces dichotomously—either
smoking or not smoking—smoking was not
permitted everywhere in most “smoking work-
places.” Included, but not emphasized, in the
written submissions Jenkins presented to
OSHA (Jenkins 1994a; Jenkins and Guerin
1994, 1995a) were data that indicated that
> 68% of the 16 Cities Study’s “smoking
workplaces” restricted smoking to designated
smoking areas only. The same data (Jenkins
1994a, Table 6) show that median concentra-
tions of nicotine in the restricted smoking
workplaces was 0.088 µg/m3 compared with
0.575 µg/m3—6.5 times greater—in “smok-
ing workplaces” with no restrictions on smok-
ing, although he did not highlight this point.
Hammond et al. (1995) reported a median
nicotine concentration in ofﬁces that restricted
smoking of 1.3 µg/m3, compared with 8.6
µg/m3 in ofﬁces without restrictions—a ratio
of 6.6, remarkably similar to the 6.5 found in
the 16 Cities data. The 1996 16 Cities Study
paper (Jenkins et al. 1996) made no distinc-
tions between workplaces that did and did not
restrict smoking to designated areas, even
though smoking restrictions reduce SHS
concentrations significantly. Jenkins and
Counts (1999) did present a more detailed
breakout of the unrestricted and restricted
smoking workplace data in 1999, although
they neither highlighted nor discussed the
different concentrations observed. 
The 16 Cities data, as we present them in
Figure 1, make two observations readily
apparent: First, fewer than half (47%) the data
from “smoking workplaces” are drawn from
workplaces that have no restrictions on smok-
ing. Second, SHS concentrations are much
higher where there are no restrictions than in
workplaces that restrict smoking (3.4 com-
pared with 1.1 µg/m3 mean nicotine, when
smoking is observed). Thus, even though the
study was designed to have 50% of its sample
people who worked in smoking workplaces,
only 10% worked where smoking was allowed
without restriction. Another 12% worked
where smoking was restricted to designated
areas, and less than a third of these subjects
observed smoking at any time during the day.
Moreover, those who did observe smoking
reported fewer cigarettes than reported by
those from workplaces without restrictions.
These observations hold if other tobacco-spe-
cific markers (e.g., 3-ethenylpyridine and
myosmine) are examined. Jenkins himself
reported this problem of too few subjects with
ETS exposure at work to CIAR’s Eisenberg in
1993 (Jenkins 1993), early in the conduct of
the study; he did not highlight it in the public
reports of the results, even though this serious
problem persisted. 
Inappropriate comparisons among the cells.
One of the key conclusions in the Jenkins et al.
(1996) 16 Cities paper is, “For the majority of
subjects who either lived or worked in smoking
environments, the home was found to be the
greater source of ETS exposure.” This conclu-
sion is based on a comparison of exposures of
Barnes et al.
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Figure 1. Effect of smoking policy and practice on the SHS exposures of workers. TWA, time-weighted aver-
age. The concentrations of nicotine observed among personal samples collected while at work varied with
smoking policy. Smoke-free policies led to much lower concentrations of SHS than policies that restricted
smoking to designated areas, but such restrictive policies did reduce SHS concentrations from the levels
observed in workplaces without any policies restricting smoking. The categorization by Jenkins et al. (1996)
of workplaces that restricted smoking to designated areas as “smoking workplaces” diluted this pool and
so substantially reduced the reported SHS concentrations in “smoking workplaces.” Because over half the
“smoking workplaces” in fact restricted smoking and the SHS concentrations where smoking was not
restricted were > 6 times greater than where they were restricted, the mean reported was half the value
that would have been observed had the correct categorization been used (including workplaces that
allowed smoking without restrictions). Data from Jenkins and Counts (1999, Table 2). those who live with smokers to those who
work with smokers. However, the more rele-
vant question to the OSHA proceedings (and
any consideration of smoke-free workplace
policies) is whether workplace exposure to
SHS adds signiﬁcantly to the total SHS expo-
sure experienced by individuals. Rather than
grouping all the data, Jenkins et al. (1996)
could have stratified the data by the home
smoking status and then reported the relative
exposures of those who work in smoking
environments and those who work in non-
smoking environments.
Although not making this comparison
themselves, Jenkins et al. (1996, Table 6) do
provide data appropriate for this analysis, which
we plot in Figure 2. Among those who live in
smoking homes, working in a conﬁrmed smok-
ing workplace doubled their total 24-hr average
SHS exposures (median, mean, 80th, and 95th
percentiles) compared with those who worked
in nonsmoking environments. The effect is
even more pronounced for those who live in
nonsmoking homes: Their total exposures are
> 10 times higher if they work in smoking envi-
ronments compared with those working in
nonsmoking environments. On an absolute
scale, those exposed only at work (Cell 3,
NH/SW) experience, on average, half the 24-hr
exposure as those exposed only at home (Cell 2,
SH/NW), but this result reﬂects primarily the
fact that twice as much time is spent away from
work as at work (16 vs. 8 hr/day). These data
indicate that if workplaces were smoke-free, the
total SHS exposure of those living with smokers
could be cut in half, and the total SHS expo-
sure of those living in nonsmoking homes
would become negligible, a signiﬁcant worker
safety and public health beneﬁt. 
Real roles of the parties in the 16 Cities
Study. Table 2 compares the roles of CIAR
and its contractors in conducting the 16 Cities
Study described by Jenkins in the 16 Cities
Study (Jenkins et al. 1996). The most signiﬁ-
cant deviation between Jenkins’ description
and the actual situation is that Jenkins’
description seems to indicate that ORNL had
overall control of the study design and imple-
mentation, even though these critical func-
tions were controlled by RJR and CIAR
(Table 2). The published paper (Jenkins et al.
1996) did acknowledge the RJR scientists “for
their outstanding contributions to laboratory
and ﬁeld operations,” but they were not listed
as co-authors. In contrast, RJR’s Green wrote
in 1997 in an internal RJR memo supporting
a promotion for Ogden: “The so-called
‘16-Cities Study’ was published by ORNL sci-
entists in a peer-reviewed journal. Because of
the political beliefs of some sponsors, Dr.
Ogden and his colleagues were acknowledged
in the paper for their contributions, but were
not granted their rightful recognition as co-
authors” (Green 1997b; Ogden 1997).
In 1997 Jenkins did fully describe the
extensive role that RJR played in designing
the 16 Cities Study in the secondhand smoke
lawsuit (Broin 1991) brought against tobacco
companies by airline ﬂight attendants exposed
to in-flight SHS before smoking was elimi-
nated on all U.S. flights (Broin 1997,
14518–14564; Wilson 1997). Tobacco
industry lawyers wanted to use Jenkins and
the 16 Cities Study to show that the flight
attendants were exposed to SHS levels that
were too low to account for any of the health
problems the ﬂight attendants were claiming
resulted from in-ﬂight exposure.
After a hearing in chambers in which
Jenkins described the extensive role that RJR
played in designing the 16 Cities Study, obtain-
ing the ﬁeld sampling data and analyzing them,
and the limited role Jenkins and his ORNL col-
leagues played in data collection, Judge Robert
Paul Kaye concluded that Jenkins would not be
allowed to testify concerning his published 16
Cities Study because RJR’s extensive involve-
ment in the study raised concerns about its reli-
ability (Broin 1997, 14570–14571; Daubert
1993; General Electric 1997). 
Jenkins and colleagues later published sev-
eral papers using the 16 Cities data set that
showed that the number of cigarettes observed
in the workplace had an impact on SHS expo-
sure concentrations (LaKind et al. 1999), that
restricting smoking to designated areas reduces
nonsmoker SHS exposures (Jenkins and
Counts 1999), and that making workplaces
nonsmoking eliminates the great majority of
nonsmoker SHS exposures (Graves et al. 2000).
Tobacco industry SHS study supports smoke-free work
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Table 2. Functions of organizations in the conduct of the 16 Cities Study.
Function ORNL RJR BRI CIAR
Overall conduct of the study * A
Development of study design  P A
Selection of outside ﬁrms P Aa Ab Ac
Oversight of ﬁeld sampling P, A
Quality assurance P, A
Data study and interpretation  P, A A A
Reporting of results P, A Ad
Contracting with outside ﬁrmse A
Recruitment of human subjects P, A
Conduct ﬁeld operations P, A P, A
Conduct information coding P, A
Provide human subject data to ORNL P, A
Provide sampling material and equipment P, A
Analyze ﬁeld samples P, A
Compile analytical data P, A
Abbreviations: A, as actually performed; BRI, Bellomy Research, Inc; P, as reported by Jenkins et al. (1996) in original
published paper; R&D, research and development; *function is listed in ORNL’s original proposal to CIAR (Jenkins and
Guerin 1993) as an ORNL function, but the function is omitted entirely from the paper. 
aSelected Bellomy Research, Inc. to recruit human subjects. bSelected local marketing research firms for human sub-
jects recruitment. cSelected RJR R&D to conduct ﬁeld sampling, analyses of ﬁeld samples, and compilation of analytical
data. dCIAR directed several changes in reporting of results in the ﬁnal paper (Jenkins et al. 1996). eFunction is listed in
ORNL’s original proposal to CIAR as a CIAR function (Jenkins and Guerin 1993), but omitted entirely from the paper
(Jenkins et al. 1996). 
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Figure 2. Daily average concentrations as a function of smoking policies at home and at work. (Smoking
workplaces include those that restrict smoking to designated areas.) The 24-hr concentrations are the
average of the 8-hr “at work” and the 16-hr “away from work” personal samples. The daily average con-
centrations increase dramatically for those who live in nonsmoking homes if they work in an environment
that “allows smoking” (compare Cell 2 to Cell 1). Those who live in smoking homes also experience a large
increase in daily exposures if they also work where smoking is allowed or restricted (compare Cell 4 to
Cell 3). Clearly whether or not one works where smoking is allowed has a signiﬁcant impact on the total
daily exposure. Other tobacco specific markers of SHS demonstrate similar relationships. Data from
Jenkins et al. (1996, Table 6).Barnes et al.
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It is important to emphasize, however, that this
work was published long after the close of the
OSHA proceedings, and influencing OSHA
was the primary reason for the 16 Cities Study.
The broader implications of the 16 Cities
Study. Although the results of industry-funded
research consistently reﬂect a bias in support of
the sponsors’ interests (Bekelman et al. 2003;
Bero 2005a; Bero and Rennie 1996; Bhandari
et al. 2004; Boyd and Bero 2000; Boyd et al.
2003; Cho and Bero 1996; Glaser and Bero
2005; Levine et al. 2003; Lexchin et al. 2003;
Lipton et al. 2004; Martinson et al. 2005;
Yaphe et al. 2001), it is only because of the
public availability of millions of pages of inter-
nal tobacco industry documents that we can
examine the mechanics of the tobacco indus-
try’s efforts (Bero et al. 2005; Bitton et al.
2005; Malone and Bero 2003; McKee 2003;
Shamasunder and Bero 2002; Tong et al.
2005) to develop and present scientiﬁc results
specifically designed to support its corporate
advocacy efforts. This detailed understanding
leads to some principles that can be applied
generally. Research funded by an industry
seeking to affect regulation should be reviewed
and analyzed very critically, particularly for
subtle forms of inﬂuence on the presentation
of results. Journals should require not only dis-
closure of funding but also disclosure of the
involvement of the sponsor in the conduct of
the research and preparation and revision of
the resulting papers, such as already required
by The Lancet (Lancet 2006).
Conclusion 
The 16 Cities Study, as with the conclusions of
the 1998 aircraft cabin air quality study con-
ducted for the tobacco industry (Neilsen and
Glantz 2003), offers an example in which
researchers funded by the tobacco industry
minimized the involvement of the industry in
the actual conduct of a research project and
presented the results in a way that supported
the industry’s political or legal position. The
16 Cities Study was speciﬁcally conceived and
designed to forestall regulation of workplace
smoking. The extensive involvement of RJR,
in particular, in the design and execution of the
study, was never clearly disclosed in any of the
publications or public presentations of the
results. The study authors combined exposure
data from restricted and unrestricted work-
places and compared exposure data among
study cells in an inappropriate manner. That
analysis produced results the industry could
cite to support its claim that workplace SHS
exposures were low compared with household
exposures during its efforts to defeat indoor
smoking restrictions. In fact, an alternative pre-
sentation of the same data (Figure 2) demon-
strates significant workplace secondhand
smoke exposures and supports the need for
smoke-free workplaces.
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